Results 221 to 230 of about 141,025 (360)

Essential Updates 2024/2025: History, Pathogenesis, Definition, Prevention, and Management of Small‐for‐Size Syndrome in Living‐Donor Liver Transplantation

Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 35-41, January 2026.
ABSTRACT Although living‐donor liver transplantation (LDLT) has become the standard treatment for end‐stage liver disease, one of its major challenges is small‐for‐size syndrome (SFSS). SFSS is characterized by severe icterus and intractable ascites, although the severity of the condition can vary.
Toru Ikegami, Masashi Tsunematsu, Shinji Onda, Kenei Furukawa, Koichiro Haruki, Michinori Matsumoto, Yoshihiro Shirai   +6 more
wiley   +1 more source

Autonomic Contribution to Endothelin-1 Increase during Laboratory Anger-Recall Stress in Patients with Coronary Artery Disease [PDF]

, 2011
Matthew M. Burg, Aaron Soufer, Rachel Lampert, Dorothea Collins, Robert Soufer   +4 more
openalex   +1 more source

Network and Gene Set Enrichment Analysis of Adipokine Drivers of Prostate Cancer; Unravelling the Mechanistic Link Between Excess Adiposity and Prostate Cancer Risk

Cancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Background Adiposity‐Based Chronic Disease (ABCD), a novel model housing obesity, insulin resistance, and adipokine‐related inflammation, increases the risk of aggressive prostate cancer (PCa), posttreatment PCa recurrence, and PCa mortality. This paper provides a new network analysis of relevant metabolic drivers to provide insight into the ...
Zachary Dovey, Elena Tomas Bort, Jeffrey I. Mechanick   +2 more
wiley   +1 more source

Endothelin-1 in combination with CRB-65 enhance risk stratification in COVID-19 patients. [PDF]

Infection
Farhat I, Rosolowski M, Ahrens K, Lienau J, Ahnert P, Pletz M, Rohde G, Rupp J, Witzenrath M, Scholz M, CAPNETZ Study Group, PROGRESS Study Group.   +11 more
europepmc   +1 more source

Clinical Significance of Acute-Phase Endothelin-1 in Acute Myocardial Infarction Patients Treated With Direct Coronary Angioplasty

, 2005
Toshiro Katayama, Katsusuke Yano, Hiroshi Nakashima, Chisa Takagi, Yukiharu Honda, Shin Suzuki, Yoshihiro Iwasaki   +6 more
openalex   +2 more sources

Identification and characterization of two isoforms of an endothelin‐converting enzyme‐1 [PDF]

, 1995
Kohei Shimada, Masaaki Takahashi, Masahiro Ikeda, Kazuhiko Tanzawa   +3 more
openalex   +1 more source

Design and Synthesis of Novel Purine Analogues as Potential IL‐1β Inhibitors Targeting Vascular Inflammation

Chemistry &Biodiversity, Volume 23, Issue 1, January 2026.
Initial screening of the synthesized compounds revealed that compounds MK175 and MK169 inhibited LPS‐induced IL‐1β release in human aortic smooth muscle cells. ABSTRACT Proinflammatory cytokine interleukin (IL)‐1β is a key mediator of the inflammatory response in atherosclerosis.
Dimitra T. Pournara, Theano Fotopoulou, Geena Paramel, Madelene Lindkvist, Magnus Grenegård, Karin Fransén, Maria Koufaki   +6 more
wiley   +1 more source

Autoantibodies directed against the angiotensin II type 1 receptor and the endothelin-1 type A receptor in patients with systemic sclerosis. [PDF]

RMD Open
van der Wouden KE, Ahmed S, van Oostveen WM, Hoekstra EM, Liem SIE, Huizinga TWJ, Toes REM, Voskuyl AE, Riemekasten G, Fehres CM, Vonk M, de Vries-Bouwstra JK.   +11 more
europepmc   +1 more source

Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1 [PDF]

, 2017
Jale Yüzügülen, Julie A. Douthwaite, Elizabeth G. Wood, Inmaculada Concepción Villar, Nimesh S. A. Patel, J Jegard, Hubert Gaertner, Irène Rossitto-Borlat, Keith Rose, Oliver Hartley, Pedro R. Cutillas, Amrita Ahluwalia, Roger Corder   +12 more
openalex   +1 more source

A Case of Atrial Septal Defect Unveiled by the Treatment for Pulmonary Arterial Hypertension

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT We present a case of a 51‐year‐old woman with atrial septal defect (ASD) masked by pulmonary arterial hypertension (PAH). Three months after PAH treatment with a combination of endothelin receptor antagonist and phosphodiesterase five inhibitor, the transthoracic echocardiography revealed left‐to‐right shunting through a secundum ASD.
Takaaki Fujii, Sayuri Yamabe, Yoshiro Tsuruta, Yu Kawada, Tatsuya Mizoguchi, Masashi Yokoi, Kento Mori, Tsuyoshi Ito, Shuichi Kitada, Toshihiko Goto, Shigefumi Fukui, Hideo Izawa, Yoshihiro Seo   +12 more
wiley   +1 more source